Biocept, Inc. (NASDAQ: BIOC)
Biocept has been a fun one to watch in the market recently. With so much volatility, the stock has presented opportunity after opportunity for gains; and today, it climbs again! Yesterday morning, an announcement was made that Biocept’s CEO will be giving a presentation relatively soon. Today, we’ll talk about the when, where and why of the presentation, as well as what we can expect to see from the stock moving forward. So, lets get right to it.
BIOC CEO To Present At The LD Micro Invitational Conference
Biocept announced yesterday that Michael Nail, President and CEO of the company, will be giving a presentation at the LD Micro Invitational Conference on June 1, at 1:00PM Pacific time. In the announcement the company stated that the CEO would be offering a corporate overview in his presentation. The conference will be held at the Luxe Sunset Bel Air hotel in Los Angeles. However, if you can’t make it there, you’re not out of luck! The presentation will also be aired via live webcast on the company’s corporate website ir.biocept.com and will be available in the archive for 90 days.
What We’re Seeing From BIOC Today
As mentioned above, Biocept is having a great day in the market today. Following the news, investors seem to be excited with regard to what they can expect from the presentation. As a result, the value of BIOC is currently (12:17) $3.01 per share after a gain of 4.60% so far today.
What We Can Expect To See From Biocept Moving Forward
When it comes to Biocept, I think that we’re likely to see gains in both the short term and long term outlooks. Here’s how I see it…
- Short Term – In the short run, I’m expecting to see incredibly positive news on June 1st in the presentation from the company’s CEO. Since Biocept is a small-cap biotech company, we can expect any news to cause big movements in the stock. So, with positive news on the corporate outlook of the company, I’m expecting to see the stock moving upward on June 2nd, and for a short while following.
- Long Term – In the long term, I’m a huge fan of BIOC. The company has found a way to detect cancer through the biopsy of a simple blood sample…that’s absolutely AMAZING! At this point, they’ve added several new tests to their portfolio; most recently adding a test that’s designed to pinpoint patients that are susceptible to the ailment. When we couple Biocept’s incredible product with a strong core management team and a clear plan, it seems as though the company can only grow in the long run.
What Do You Think?
Where do you think BIOC is headed and why? Let us know in the comments below!